Given the magnitude of the opioid crisis in the United States, a growing number of patient advocates are calling for primary care physicians to assume greater responsibility for treatment of those with opioid use disorder.
Yet while these primary care physicians are positioned to offer this treatment — and are already allowed to prescribe buprenorphine and naloxone treatment — many choose not to, citing a lack of institutional support and discomfort managing the more complex medical needs sometimes associated with this disorder.
To better understand the needs of patients with opioid use disorder and treatment options, Yale researchers analyzed the health records of 355 patients treated in a primary care facility at the APT Foundation in New Haven, Connecticut.
According to their findings, published Dec. 10 in the journal Family Practice, the needs of those patients were largely similar to those of the average adult patient.
“We thought that if it turned out these patients were not particularly complicated, then it might help encourage primary care providers to offer treatment,” said Cindy Du, a fourth-year medical student at the Yale School of Medicine and lead author of the study.
“Concerns that patients with opioid use disorder have complex medical needs have been suggested as a possible barrier to primary care providers offering opioid treatment,” she said. “But our findings suggest these patients have similar clinical needs as the general population. Their main medical concerns are what primary care doctors are used to treating.”
In general, patients with opioid use disorder reported the same medical concerns as those dealing with other ailments, including chronic pain and psychiatric disorders, Du and her colleagues found. The two most common types of medication used by patients with opioid use disorder were antidepressants and cardiovascular medications, which are also the most commonly used medications among all U.S. adults.
“The other most common medications were over the counter pain treatments, like Tylenol and ibuprofen, which a lot of people use, not just patients with opioid use disorder,” said Du.
In previous studies, some primary care physicians relayed concerns about treating infectious diseases believed to be associated with opioid use disorder, such as HIV and hepatitis, because they tend to have less experience with those types of illnesses. But among the patients included in the study, few were being treating for infectious diseases. Just 7% of patients were under treatment for hepatitis C and none for HIV.
Along with the ongoing legal and advocacy work being done to prevent opioid use disorder, expanded treatment access is key to tackling the opioid epidemic, Du said. “In terms of treating people that have opioid use disorder now, having more primary care doctors and non-addiction specialist centers providing opioid treatment is certainly going to be an important part,” Du said. “Especially in rural areas or areas with less access to specialty centers.”
She also noted that institutional support — including additional staff, space, and access to specialists — could help facilitate willingness among primary care providers. “Primary care doctors already deal with a lot,” said Du. “Ensuring they feel fully supported may encourage more to offer opioid treatment.”
This story was originally published by Yale University on December 16th, 2022